Prognostic Factors of Hospitalization for Patients Aged 75 and Over in Emergency Department in France - Monocentric Retrospective Cohort Study (PROFACTHOS)

March 10, 2026 updated by: Poitiers University Hospital

Prognostic Factors of Hospitalization for Patients Aged 75 and Over in Emergency Department in France - Monocentric Retrospective Cohort Study - PROFACTHOS

A geriatric patient is defined as a patient aged 75 and over who meets certain medical or social vulnerability criteria and is characterised by coexisting physical and/or psychological dependence. The proportion of patients with a geriatric profile in the general population is growing. The average time spent in the emergency department by the elderly population is about 3 hours longer than for patients under 75 years old in France, which is associated with the risk of decompensation of chronic conditions, confusion, falls or agitation. An overnight stay in the emergency department for these patients increases the risk of mortality and the length of hospital stay.

Several prognostic scores for hospitalization have been studied in adult populations. The most widely used scores are the Sydney Triage to Admission Risk Tool (START), the Ambulatory (AMB) and the Glasgow Admission Prediction Score (GAPS). Studies have compared these three scores and demonstrated the greater robustness of GAPS. The CalcuLation of the Elderly Admission Risk in the Emergency Department (CLEARED) tool, developed for the elderly population, has lower performance than GAPS. A systematic review of the literature studied the power of GAPS for the geriatric population and highlighted the need for validation in the target population. No validated hospitalization prognostic score was found in France for this population. The research hypothesis is that GAPS would detect hight probability of admission at the time of triage for the patients aged 75 and over in emergency department in France. The primary objective of this monocentric study is to evaluate the prognostic performance of GAPS for the target population (on the group 1). The secondary objectives consist of developing and internally validating a new score (PROFACTHOS) (on the group 2), then performing a temporal validation of PROFACTHOS with comparison to the GAPS (on the group 1), and finally to determine the threshold for classifying patients with a high probability of hospitalization for the score with the strongest discriminatory performance among GAPS or PROFACTHOS.

Group 1: Patients aged 75 and over admitted to emergency department from 10/01/2024 to 09/30/2025.

Group 2 : Patients aged 75 and over admitted to emergency department from 10/01/2022 to 09/30/2023

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

967

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Elderly patients, over or equal 75 years old, admitted to the emergency department in the inclusion period

Description

Inclusion Criteria:

  • Adult over or equal 75 years old
  • Patient admitted to the emergency department between 10/01/2022 and 09/30/2023 for the second group, and between 10/01/2024 and 09/30/2025 for the first group
  • Patient and/or family and/or trusteeship who doesn't refused to participate

Exclusion Criteria:

  • Patient died before admitted to emergency department
  • Patient already included in the study
  • File created by mistake, identified by the mention "Erreur de dossier"
  • Patient deprived of total or partial liberty by a judicial or administrative decision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate the prognostic performance of GAPS in a population of patients aged 75 and over admitted to emergency departments in France
Time Frame: 1 day
The performance of GAPS will be evaluated by measuring the area under the ROC (receiver operating characteristic) curve (AUC) with the population of group 1.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To develop a prognostic hospitalization score (PROFACTHOS) based on data from the patient's initial clinical exam.
Time Frame: 1 day
The PROFACTHOS prognostic score will be developed to predict the following binary event: hospitalization of the patient at the end of treatment. Potential predictive factors were established based on existing literature and by consulting a team of emergency physicians and geriatricians at Poitiers University Hospital. The performance of the prognostic score will be evaluated using the AUC (area under the ROC curve) and the Brier score. It will be carried out with the population of group 2.
1 day
Temporal validation of the hospitalization prognostic score PROFACTHOS
Time Frame: 1 day
The PROFACTHOS hospitalization prognostic score will be temporally validated using data from a time period independent of that used for its construction, with patients from group 1. The performance of the score will be measured by the area under the ROC (receiver operating characteristic) curve (AUC) and the Brier score.
1 day
To compare the performance of both scores GAPS and PROFACTHOS
Time Frame: 1 day
The prognostic performance of the GAPS and PROFACTHOS scores will be evaluated and compared by their AUC, with patients from group 1.
1 day
To determine the threshold for classifying patients with a high probability of hospitalization for the score with the strongest discriminatory performance among GAPS or PROFACTHOS
Time Frame: 1 day
The threshold will be determined in order to obtain optimal positive and negative predictive values.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 15, 2026

Primary Completion (Estimated)

March 15, 2027

Study Completion (Estimated)

April 15, 2027

Study Registration Dates

First Submitted

March 10, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 16, 2026

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • PROFACTHOS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elderly

Subscribe